Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats

Journal of Neurochemistry

Volumn 129, Issue 3, 2014, Pages 484-494

  Vidal Torres, Alba ^a   Fernández Pastor, Begoña ^a   Carceller, Alicia ^a   Vela, José Miguel ^a   Merlos, Manuel ^a   Zamanillo, Daniel ^a  

^a National Institute of Bioinformatics   (Spain)

Author keywords

concentric microdialysis; glutamate; noradrenaline; S1RA; sigma 1 receptor; spinal cord

Indexed keywords

CONCENTRIC MICRODIALYSIS; GLUTAMATE; NORADRENALINE; S1RA; SIGMA-1 RECEPTOR; SPINAL CORD;

ANIMALS; BEHAVIOR, ANIMAL; MALE; MICRODIALYSIS; MORPHOLINES; NEURALGIA; NEUROTRANSMITTER AGENTS; PAIN MEASUREMENT; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, SIGMA; SPINAL CORD;

EID: 84899446901     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12648     Document Type: Article

References (64)

1. Abbott F. V., Franklin K. B., and, Westbrook R. F., (1995) The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60, 91-102.
2. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., and, Maurice T., (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97, 155-170.
3. Baba H., Goldstein P. A., Okamoto M., Kohno T., Ataka T., Yoshimura M., and, Shimoji K., (2000a) Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 2): effects on somatodendritic sites of GABAergic neurons. Anesthesiology 92, 485-492.
4. Baba H., Shimoji K., and, Yoshimura M., (2000b) Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 1): effects on axon terminals of GABAergic and glycinergic neurons. Anesthesiology 92, 473-484.
5. Cendán C. M., Pujalte J. M., Portillo-Salido E., and, Baeyens J. M., (2005a) Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology 182, 485-493.
6. Cendán C. M., Pujalte J. M., Portillo-Salido E., Montoliu L., and, Baeyens J. M., (2005b) Formalin-induced pain is reduced in sigma(1) receptor knockout mice. Eur. J. Pharmacol. 511, 73-74.
7. Chaplan S. R., Malmberg A. B., and, Yaksh T. L., (1997) Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J. Pharmacol. Exp. Ther. 280, 829-838.
8. Cobos E. J., Entrena J. M., Nieto F. R., Cendán C. M., and, del Pozo E., (2008) Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr. Neuropharmacol. 6, 344-366.
9. Coderre T. J., Yashpal K., and, Henry J. L., (1994) Specific contribution of lumbar spinal mechanisms to persistent nociceptive responses in the formalin test. NeuroReport 5, 1337-1340.
10. Díaz J. L., Zamanillo D., Corbera J., Baeyens J. M., Maldonado R., Pericàs M. A., Vela J. M., and, Torrens A., (2009) Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain. Cent. Nerv. Syst. Agents Med. Chem. 9, 172-183.
11. Díaz J. L., Cuberes R., Berrocal J., et al,. (2012) Synthesis and biological evaluation of the 1-arylpyrazole class of sigma(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3- yloxy]ethyl}morpholine (S1RA, E-52862). J. Med. Chem. 55, 8211-8224.
12. Dong L. Y., Cheng Z. X., Fu Y. M., Wang Z. M., Zhu Y. H., Sun J. L., Dong Y., and, Zheng P., (2007) Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor. Neuropharmacology 52, 966-974.
13. Dooley D. J., Mieske C. A., and, Borosky S. A., (2000) Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci. Lett. 280, 107-110.
14. Drews E., and, Zimmer A., (2009) Central sensitization needs sigma receptors. Pain 145, 269-270.
15. Gassner M., Ruscheweyh R., and, Sandkühler J., (2009) Direct excitation of spinal GABAergic interneurons by noradrenaline. Pain 145, 204-210.
16. González-Cano R., Merlos M., Baeyens J. M., and, Cendán C. M., (2013) sigma1 receptors are involved in the visceral pain induced by intracolonic administration of capsaicin in mice. Anesthesiology 118, 691-700.
17. Grudt T. J., and, Williams J. T., (1995) Opioid receptors and the regulation of ion conductances. Rev. Neurosci. 6, 279-286.
18. Guitart X., Codony X., and, Monroy X., (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology 174, 301-319.
19. Hayashi T., and, Su T. P., (2003) Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J. Pharmacol. Exp. Ther. 306, 718-725.
20. Hayashi T., Justinova Z., Hayashi E., Cormaci G., Mori T., Tsai S. Y., Barnes C., Goldberg S. R., and, Su T. P., (2010) Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J. Pharmacol. Exp. Ther. 332, 1054-1063.
21. Hayashi T., Tsai S. Y., Mori T., Fujimoto M., and, Su T. P., (2011) Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin. Ther. Targets 15, 557-577.
22. Hayashida K., DeGoes S., Curry R., and, Eisenach J. C., (2007) Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106, 557-562.
23. Heapy C. G., Jamieson A., and, Russell N. J. W., (1987) Afferent C-fibre and A-delta activity in models of inflammation. Br. J. Pharmacol. 90, 164.
24. Jun J. H., and, Yaksh T. L., (1998) The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth. Analg. 86, 348-354.
25. Kibaly C., Meyer L., Patte-Mensah C., and, Mensah-Nyagan A. G., (2008) Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord. FASEB J. 22, 93-104.
26. Kim H. W., Kwon Y. B., Han H. J., Yang I. S., Beitz A. J., and, Lee J. H., (2005) Antinociceptive mechanisms associated with diluted bee venom acupuncture (apipuncture) in the rat formalin test: involvement of descending adrenergic and serotonergic pathways. Pharmacol. Res. 51, 183-188.
27. Kim H. W., Kwon Y. B., Roh D. H., Yoon S. Y., Han H. J., Kim K. W., Beitz A. J., and, Lee J. H., (2006) Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. Br. J. Pharmacol. 148, 490-498.
28. Kim H. W., Roh D. H., Yoon S. Y., Seo H. S., Kwon Y. B., Han H. J., Kim K. W., Beitz A. J., and, Lee J. H., (2008) Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br. J. Pharmacol. 154, 1125-1134.
29. Kumar N., Cherkas P. S., Varathan V., Miyamoto M., Chiang C. Y., Dostrovsky J. O., Sessle B. J., and, Coderre T. J., (2013) Systemic pregabalin attenuates facial hypersensitivity and noxious stimulus-evoked release of glutamate in medullary dorsal horn in a rodent model of trigeminal neuropathic pain. Neurochem. Int. 62, 831-835.
30. Kuraishi Y., Hirota N., Sato Y., Kaneko S., Satoh M., and, Takagi H., (1985) Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res. 359, 177-182.
31. Kwon Y. B., Jeong Y. C., Kwon J. K., Son J. S., and, Kim K. W., (2009) The Antinociceptive effect of sigma-1 receptor antagonist, BD1047, in a capsaicin induced headache model in rats. Korean J. Physiol. Pharmacol. 13, 425-429.
32. Lee B. S., Jun I. G., Kim S. H., and, Park J. Y., (2012) Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain. J. Korean Med. Sci. 27, 430-436.
33. Liu X. J., and, Salter M. W., (2010) Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Eur. J. Neurosci. 32, 278-289.
34. Lu C. W., Lin T. Y., Wang C. C., and, Wang S. J., (2012) Sigma-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings. J. Pharmacol. Exp. Ther. 341, 532-542.
35. Malmberg A. B., and, Yaksh T. L., (1995a) Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci. 15, 2768-2776.
36. Malmberg A. B., and, Yaksh T. L., (1995b) The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. Br. J. Pharmacol. 114, 1069-1075.
37. Marsala M., Malmberg A. B., and, Yaksh T. L., (1995) The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J. Neurosci. Methods 62, 43-53.
38. Maurice T., and, Su T. P., (2009) The pharmacology of sigma-1 receptors. Pharmacol. Ther. 124, 195-206.
39. McGrath J. C., Drummond G. B., McLachlan E. M., Kilkenny C., and, Wainwright C. L., (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br. J. Pharmacol. 160, 1573-1576.
40. Mei J., and, Pasternak G. W., (2002) Sigma1 receptor modulation of opioid analgesia in the mouse. J. Pharmacol. Exp. Ther. 300, 1070-1074.
41. Mei J., and, Pasternak G. W., (2007) Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study. J. Pharmacol. Exp. Ther. 322, 1278-1285.
42. Meyer D. A., Carta M., Partridge L. D., Covey D. F., and, Valenzuela C. F., (2002) Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J. Biol. Chem. 277, 28725-28732.
43. Millan M. J., (2002) Descending control of pain. Prog. Neurobiol. 66, 355-474.
44. Nicholas A. P., Pieribone V., and, Hokfelt T., (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 328, 575-594.
45. Nieto F. R., Cendán C. M., Sánchez-Fernández C., Cobos E. J., Entrena J. M., Tejada M. A., Zamanillo D., Vela J. M., and, Baeyens J. M., (2012) Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J. Pain 13, 1107-1121.
46. North R. A., and, Yoshimura M., (1984) The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J. Physiol. 349, 43-55.
47. Okura T., Komiyama N., Morita Y., Kimura M., and, Yamada S., (2007) Different effects of morphine and morphine-6beta-glucuronide on formalin-evoked spinal glutamate release in conscious and freely moving rats. Neurosci. Lett. 415, 169-173.
48. Phan V. L., Miyamoto Y., Nabeshima T., and, Maurice T., (2005) Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse. J. Neurosci. Res. 79, 561-572.
49. Pogatzki E. M., Zahn P. K., and, Brennan T. J., (2000) Lumbar catheterization of the subarachnoid space with a 32-gauge polyurethane catheter in the rat. Eur. J. Pain 4, 111-113.
50. Porreca F., Ossipov M. H., and, Gebhart G. F., (2002) Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319-325.
51. de la Puente B., Nadal X., Portillo-Salido E., et al,. (2009) Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury. Pain 145, 294-303.
52. Romero L., Zamanillo D., Nadal X., et al,. (2012) Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization. Br. J. Pharmacol. 166, 2289-2306.
53. Sánchez-Fernández C., Nieto F. R., González-Cano R., Artacho-Cordõn A., Romero L., Montilla-García Á., Zamanillo D., Baeyens J. M., Entrena J. M., and, Cobos E. J., (2013) Potentiation of morphine-induced mechanical antinociception by sigma(1) receptor inhibition: role of peripheral sigma(1) receptors. Neuropharmacology 70, 348-358.
54. Schlicker E., and, Kathmann M., (2008) Presynaptic neuropeptide receptors. Handb. Exp. Pharmacol. 184, 409-434.
55. Storkson R. V., Kjorsvik A., Tjolsen A., and, Hole K., (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods 65, 167-172.
56. Takeuchi Y., Takasu K., Ono H., and, Tanabe M., (2007) Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. Neuropharmacology 53, 842-853.
57. Tsai S. Y., Hayashi T., Mori T., and, Su T. P., (2009) Sigma-1 receptor chaperones and diseases. Cent. Nerv. Syst. Agents Med. Chem. 9, 184-189.
58. Ueda M., Oyama T., Kuraishi Y., Akaike A., and, Satoh M., (1995) Alpha 2-adrenoceptor-mediated inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neurosci. Lett. 188, 137-139.
59. Ueda H., Inoue M., Yoshida A., Mizuno K., Yamamoto H., Maruo J., Matsuno K., and, Mita S., (2001) Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice. J. Pharmacol. Exp. Ther. 298, 703-710.
60. Vidal-Torres A., Carceller A., Zamanillo D., Merlos M., Vela J. M., and, Fernández-Pastor B., (2012) Evaluation of formalin-induced pain behavior and glutamate release in the spinal dorsal horn using in vivo microdialysis in conscious rats. J. Pharmacol. Sci. 120, 129-132.
61. Vidal-Torres A., de la Puente B., Rocasalbas M., et al,. (2013) Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects. Eur. J. Pharmacol. 711, 63-72.
62. Wheeler-Aceto H., and, Cowan A., (1991) Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 104, 35-44.
63. Wolff M., Heugel P., Hempelmann G., Scholz A., Muhling J., and, Olschewski A., (2007) Clonidine reduces the excitability of spinal dorsal horn neurones. Br. J. Anaesth. 98, 353-361.
64. Zamanillo D., Romero L., Merlos M., and, Vela J. M., (2013) Sigma 1 receptor: a new therapeutic target for pain. Eur. J. Pharmacol. 716, 78-93.